Onglyza 5mg works by inhibiting the enzyme DPP-4, which normally breaks down incretin hormones. Increasing incretin activity helps promote glucose-dependent insulin release and reduce glucagon secretion.

This mechanism supports better blood glucose regulation without directly supplying insulin. Onglyza may be prescribed alone or alongside other diabetes medicines depending on the patient’s treatment requirements.

Brand: Onglyza

Active Ingredient: Saxagliptin 5mg

Dosage Form: Tablet

Pack Size: 14 tablets

Drug Class: DPP-4 inhibitor

Route: Oral

Take according to the prescribed diabetes treatment plan.